BUSERELIN (BUSERELIN ACETATE) — all Canadian products
6 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is BUSERELIN (BUSERELIN ACETATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02225166 | SUPREFACT | CHEPLAPHARM ARZNEIMITTEL GMBH | Solution | Subcutaneous | BUSERELIN (BUSERELIN ACETATE) 1 MG | Marketed | |
| 02225158 | SUPREFACT | CHEPLAPHARM ARZNEIMITTEL GMBH | Solution | Nasal | BUSERELIN (BUSERELIN ACETATE) 100 MCG | Cancelled Post Market | |
| 02228955 | SUPREFACT DEPOT 2 MONTHS | CHEPLAPHARM ARZNEIMITTEL GMBH | Implant | Subcutaneous | BUSERELIN (BUSERELIN ACETATE) 6.3 MG | Dormant | |
| 02240749 | SUPREFACT DEPOT 3 MONTHS | CHEPLAPHARM ARZNEIMITTEL GMBH | Implant | Subcutaneous | BUSERELIN (BUSERELIN ACETATE) 9.45 MG | Dormant | |
| 00680028 | SUPREFACT INJ 1MG/ML | HOECHST CANADA INC. | Liquid | Subcutaneous | BUSERELIN (BUSERELIN ACETATE) 1 MG | Cancelled Post Market | |
| 01989669 | SUPREFACT LIQ 1MG/ML | HOECHST ROUSSEL CANADA INC. | Liquid | Nasal | BUSERELIN (BUSERELIN ACETATE) 1 MG | Cancelled Post Market |
Browse other molecules: